Page last updated: 2024-09-05

alagebrium and thiamine

alagebrium has been researched along with thiamine in 4 studies

Compound Research Comparison

Studies
(alagebrium)
Trials
(alagebrium)
Recent Studies (post-2010)
(alagebrium)
Studies
(thiamine)
Trials
(thiamine)
Recent Studies (post-2010) (thiamine)
83103110,6753021,838

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imaizumi, T; Yamagishi, S1
Nakamura, J1
Forbes, J; Griffith, R; Horne, S; Krautwald, M; Leech, D; Münch, G; Rahmadi, A; Steele, ML1
Engelen, L; Schalkwijk, CG; Stehouwer, CD1

Reviews

3 review(s) available for alagebrium and thiamine

ArticleYear
[Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6

    Topics: Animals; Clinical Trials as Topic; Depression, Chemical; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Humans; Oxidative Stress; Pyridoxamine; Thiadiazoles; Thiamine; Thiazoles; Thiazolidines

2005
[Development of therapeutic agents for diabetic neuropathies].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6

    Topics: Aldehyde Reductase; Antioxidants; C-Peptide; Diabetic Neuropathies; Drug Design; Enzyme Inhibitors; Genetic Therapy; Glycation End Products, Advanced; Hedgehog Proteins; Humans; Indoles; Maleimides; Nerve Growth Factor; Oxidative Stress; Polymers; Protein Kinase C; Rhodanine; Thiadiazoles; Thiamine; Thiazoles; Thiazolidines; Trans-Activators; Vascular Endothelial Growth Factor A

2005
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
    Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:8

    Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme Inhibitors; Evidence-Based Medicine; Female; Glycation End Products, Advanced; Guanidines; Humans; Hyperglycemia; Male; Pyridoxamine; Thiamine; Thiazoles; Treatment Outcome

2013

Other Studies

1 other study(ies) available for alagebrium and thiamine

ArticleYear
The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase.
    Rejuvenation research, 2011, Volume: 14, Issue:4

    Topics: Animals; Binding Sites; Cattle; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme Assays; Glycation End Products, Advanced; Inhibitory Concentration 50; Kidney; Kinetics; Models, Molecular; Nucleoside-Diphosphate Kinase; Protein Kinase Inhibitors; Thiamine; Thiamine Pyrophosphate; Thiazoles

2011